About us
Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health.
With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients.
San Francisco – New York – London – Cambridge – Paris – Basel – Shanghai
San Francisco
New York
Basel
Paris
London
Cambridge
Cambridge
Shanghai
Our Strategy
We back venture- and growth-stage companies
with emerging technologies that catalyze groundbreaking advances in healthcare.
We fund future leaders in tech-enabled medicine
with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost.
We invest in Series A to C rounds
with the ability to lead or co-invest, and help companies scale across borders
Our Focus Areas
- Life Science Tools
- Diagnostics
- Clinical Trial Innovation
- New Care Models
- Novel Devices & Materials
- Advanced Therapeutics
Why Cathay Health
A global platform catalyzing cross-industry collaboration
Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges.
Scaling companies to transform health across borders
Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide.
Deep expertise in both healthcare and technology
Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care.
Meet Our Team
Investing & operating at the convergence
Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.
Our Portfolio Companies
Specialist CDMO serving gene and cell therapy developers
Biomorphic programmable polymers enabling atraumatic tissue repair
Next generation co-manipulation surgical robots for soft tissue surgeries
Pre-clinical biotech developing drugs targeting the ferroptosis pathway
Robotic assistance technologies for orthopedic surgeries
Venture studio creating tomorrow’s health tech solutions
Latest News